Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Magnetic Resonance in Chemistry : MRC|October 1, 2009
Fast targeted multidimensional NMR metabolomics of colorectal cancerC Ludwig, D G Ward, A Martin, et al.
Blood Cells, Molecules & Diseases|February 28, 2012
Hepcidin is correlated to soluble hemojuvelin but not to increased GDF15 during pregnancyA Finkenstedt, A Widschwendter, C G Brasse-Lagnel, et al.
British Journal of Cancer|January 13, 2006
Changes in the serum proteome associated with the development of hepatocellular carcinoma in hepatitis C-related cirrhosisD G Ward, Y Cheng, G N'Kontchou, et al.
British Journal of Cancer|June 7, 2006
Identification of serum biomarkers for colon cancer by proteomic analysisD G Ward, N Suggett, Y Cheng, et al.
British Journal of Cancer|April 18, 2013
Combined proteome and transcriptome analyses for the discovery of urinary biomarkers for urothelial carcinomaN J Shimwell, R T Bryan, W Wei, et al.
Omics : a Journal of Integrative Biology|October 8, 2005
Liver tumors in wild flatfish: a histopathological, proteomic, and metabolomic studyG D Stentiford, M R Viant, D G Ward, et al.
British Journal of Cancer|February 27, 2015
Protein shedding in urothelial bladder cancer: prognostic implications of soluble urinary EGFR and EpCAMR T Bryan, H L Regan, S J Pirrie, et al.
British Journal of Cancer|September 13, 2012
Macrophage migration inhibitory factor and DJ-1 in gastric cancer: differences between high-incidence and low-incidence areasN J Shimwell, D G Ward, Y Mohri, et al.
British Journal of Cancer|December 3, 2013
Urinary EpCAM in urothelial bladder cancer patients: characterisation and evaluation of biomarker potentialR T Bryan, N J Shimwell, W Wei, et al.
Scientific Reports|January 19, 2023
Properties of non-coding mutation hotspots as urinary biomarkers for bladder cancer detectionL Baxter, N S Gordon, S Ott, et al.
Pageof 5